Sign in to confirm you’re not a bot
This helps protect our community. Learn more

Targeted delivery of therapeutic RNAs only to disease-inflamed cells,no harm caused to healthy cells

TAUVOD
92.8K subscribers
1.6K views 4 years ago
Tel Aviv University's groundbreaking technology may revolutionize the treatment of a wide range of diseases and medical conditions. In the framework of this study, the researchers were able to create a new method of transporting RNA-based drugs to a subpopulation of immune cells involved in the inflammation process, and target the disease-inflamed cell without causing damage to other cells. Prof. Dan Peer, Tel Aviv University’s Vice President for Research and Development, head of the Center for Translational Medicine and a member of both the Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, and the Center for Nanoscience and Nanotechnology. ...more
...more
Targeted delivery of therapeutic RNAs only to disease-inflamed cells,no harm caused to healthy cells
20Likes
1,649Views
2021Jun 27
Tel Aviv University's groundbreaking technology may revolutionize the treatment of a wide range of diseases and medical conditions. In the framework of this study, the researchers were able to create a new method of transporting RNA-based drugs to a subpopulation of immune cells involved in the inflammation process, and target the disease-inflamed cell without causing damage to other cells. Prof. Dan Peer, Tel Aviv University’s Vice President for Research and Development, head of the Center for Translational Medicine and a member of both the Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, and the Center for Nanoscience and Nanotechnology.

TAUVOD

92.8K subscribers